These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8445075)

  • 1. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone.
    Zemtsov A; Neldner KH
    J Am Acad Dermatol; 1993 Mar; 28(3):505-6. PubMed ID: 8445075
    [No Abstract]   [Full Text] [Related]  

  • 2. Two Cases of Dermatitis Herpetiformis Successfully Treated with Tetracycline and Niacinamide.
    Wang Y; Yang B; Zhou G; Zhang F
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):273-275. PubMed ID: 30390734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide.
    Shah SA; Ormerod AD
    Clin Exp Dermatol; 2000 May; 25(3):204-5. PubMed ID: 10844495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic symptoms posing as dapsone-induced polyneuropathy in two patients with dermatitis herpetiformis.
    Fernandez-Obregon AC; Forconi RJ
    Cutis; 1988 May; 41(5):347-50. PubMed ID: 2836133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis.
    McKenna KE; Robinson J
    Br J Dermatol; 1997 Oct; 137(4):657-8. PubMed ID: 9390358
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyneuropathy in Duhring dermatitis herpetiformis].
    Dillmann U; Krämer G; Goebel HH
    Nervenarzt; 1991 Aug; 62(8):516-8. PubMed ID: 1944718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manic depression induced by dapsone in patient with dermatitis herpetiformis.
    Gawkrodger D
    BMJ; 1989 Sep; 299(6703):860. PubMed ID: 2510873
    [No Abstract]   [Full Text] [Related]  

  • 13. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine points in the management of dermatitis herpetiformis.
    Fry L
    Semin Dermatol; 1988 Sep; 7(3):206-11. PubMed ID: 3153446
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone for treatment of pruritic dermatitis (dermatitis herpetiformis and subcorneal pustular dermatosis) in dogs.
    Halliwell RE; Schwartzman RM; Ihrke PJ; Goldschmidt MH; Wood MG
    J Am Vet Med Assoc; 1977 Apr; 170(7):697-703. PubMed ID: 858685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia in dermatitis herpetiformis. The role of dapsone-induced haemolysis and malabsorption.
    Cream JJ; Scott GL
    Br J Dermatol; 1970 Apr; 82(4):333-42. PubMed ID: 5441766
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 18. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis.
    Katz SI
    Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759
    [No Abstract]   [Full Text] [Related]  

  • 19. Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus.
    Vandersteen PR; Jordon RE
    Arch Dermatol; 1974 Jul; 110(1):95-8. PubMed ID: 4607646
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of dietary gluten intake to dapsone dose in dermatitis herpetiformis.
    Mobacken H; Andersson H; Dahlberg E; Kastrup W
    Acta Derm Venereol; 1987; 67(3):267-70. PubMed ID: 2442946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.